Express Scripts Snubs Johnson & Johnson’s Hepatitis C Medication

By

photo credit: faungg's photo via photopin cc

Regional firm Johnson & Johnson and California-based Gilead are seeing their market share for hepatitis C medication challenged by Express Scripts, the nation’s largest pharmacy benefits manager, David Sell of Philly.com is reporting.

Express Scripts plans to provide only one brand of hepatitis C medication (AbbVie‘s Viekira Pak) to most new patients in its employer-sponsored health plans. Sell reported Express Scripts has chosen sides in a free marketplace of pharmaceutical companies hoping to make money by treating about 200 million patients worldwide.

 

Tags: , , , ,

Connect With Your Community

Subscribe to stay informed!

"*" indicates required fields

Hidden
VT Yes
This field is for validation purposes and should be left unchanged.
Advertisement
Creative Capital logo

You Might Also Like

Commerce

West Chester's Righteous Felon Jerky Cartel Brings the Artisan's Touch to Jerky

vanguard officeCommerce

Malvern-Based Vanguard Acquires North Carolina Office Complex for $117 Million

Rite AidPharma & Biotech

WSJ: Rite Aid Strikes Deal To Transfer Control Over To Creditors, Settle Opioid Claims

amazon packages on doorstepCommerce

For Many Local Shoppers, Amazon Offers Convenience, But Also Some Guilt